DAVID G MORRIS
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology HATTIESBURG, MS NPI 1477595643
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MS Astellas Pharma US Inc All categories
General Payments — all program years on this page
$5,183.41
- Category: General Payments
- Program years: PY2018–2024
- Record count: 255
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,170.31 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,170.31 | 54 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $175.50 | 8 |
| Celgene Corporation | $111.10 | 5 |
| Gilead Sciences, Inc. | $103.78 | 4 |
| Exelixis Inc. | $93.94 | 2 |
| PFIZER INC. | $93.75 | 5 |
| ABBVIE INC. | $90.32 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $80.31 | 4 |
| Octapharma USA, Inc. | $67.27 | 3 |
| E.R. Squibb & Sons, L.L.C. | $49.51 | 3 |
| Acerta Pharma LLC | $37.76 | 2 |
| Janssen Biotech, Inc. | $35.68 | 2 |
| JAZZ PHARMACEUTICALS INC. | $27.45 | 1 |
| Deciphera Pharmaceuticals Inc. | $24.30 | 1 |
| BeiGene USA, Inc. | $23.54 | 1 |
| Incyte Corporation | $22.75 | 1 |
| GlaxoSmithKline, LLC. | $21.76 | 1 |
| Lilly USA, LLC | $17.60 | 1 |
| GENZYME CORPORATION | $17.42 | 1 |
| Ipsen Biopharmaceuticals, Inc | $17.11 | 1 |
| ARRAY BIOPHARMA INC | $16.34 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $14.99 | 1 |
| Rigel Pharmaceuticals, Inc. | $14.80 | 1 |
| Merck Sharp & Dohme Corporation | $13.33 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.